Bictegravir
Back to searchMolecule Structure
Scientific Name
Bictegravir
Description of the Drug
Bictegravir is an integrase inhibitor used to treat HIV infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11799
http://www.drugbank.ca/drugs/DB11799
Brand Name(s)
Not Available
Company Owner(s)
Gilead Sciences Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Human immunodeficiency virus type 1 integrase | SINGLE PROTEIN | INHIBITOR | CHEMBL3471 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL15914278 | |
| DrugBank | DB11799 | |
| PubChem | 90311989 | |
| PDBe | KLQ | |
| BindingDB | 330048 | |
| DrugCentral | 5274 | |
| ChemicalBook | CB63161551 | |
| rxnorm | BICTEGRAVIR SODIUM | BICTEGRAVIR |
| ChEBI | 172943 |
